Credo Biomedical


Developer and manufacturer of rapid, portable point-of-care molecular diagnostic platforms and assays for human and veterinary use. The company focuses on integrated sample-to-result workflows that combine nucleic acid extraction and real-time PCR in cartridge formats, multiplex assay development, and data connectivity to healthcare information systems. Offers regulatory-cleared products and conducts post-market monitoring and assay variant analysis.

Industries

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Veterinary
Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

Credo Biomedical


Patents

Apparatus for thermal convection polymerase chain reaction

US-10688497-B2

View Details

Method of selecting analyte to samples using a lateral flow device

US-10598656-B2

View Details

Using serial dilutions of reference samples to construct a reference table for sigmoidal fitting in real-time PCR copy number analysis

US-10510436-B2

View Details

Method for detection CPV 2a, 2b, and 2c and for discrimination wild type from vaccine type

US-10233509-B2

View Details

Mixing and transfer device for materials used in biological and biochemical assays

US-10222307-B2

View Details

Products

Portable point-of-care real-time PCR instrument (human)

Compact rRT-PCR instrument for decentralized human diagnostic testing with touchscreen UI, barcode scanner, real-time fluorescence output and rapid (~20 min) turnaround for many assays.

Cartridge-based multiplex PCR platform (integrated extraction)

All-in-one microfluidic cartridge platform that integrates nucleic acid extraction and multiplex real-time PCR for automated 'sample-in, result-out' testing with multiplex capacity.

Point-of-care data integration software

Local software and interface (plug-and-play) to consolidate instrument outputs, generate reports, and transmit results securely to LIS/EMR/HIS systems.

Veterinary portable PCR platform and assay portfolio

Portable real-time PCR system and a suite of rapid veterinary assays for respiratory, gastrointestinal, blood infection and vector-borne pathogens with ~20-minute turnaround.

VitaSIRO solo™

The VitaSIRO solo TM Instrument is a rapid molecular in vitro diagnostic device utilizing magnetic beads purification and real-time polymerase chain reaction (Real-time PCR) amplification technology to process and analyze VitaSIRO solo TM tests. It performs sample preparation, nucleic acid extraction, Real-time PCR, and result interpretation for genetic material targets in specimens.

VitaSIRO solo™ Instrument

The standalone platform integrates a full workflow of nucleic acid extraction and real-time Polymerase Chain Reaction (real-time PCR) testing in a cartridge-based design, capable of detecting up to 6 targets with a wide range of sample types.

View All Products

Services

Partnering to develop and commercialize molecular diagnostic assays and translate concepts into market-ready solutions for POCT and veterinary markets.

Expertise Areas

  • Point-of-care molecular diagnostics
  • Multiplex PCR assay development and validation
  • Decentralized testing deployment and workflows
  • Veterinary molecular diagnostics
  • Show More (4)

Key Technologies

  • Real-time PCR (rRT-PCR)
  • Multiplex PCR
  • Microfluidic cartridge integration
  • Nucleic acid extraction (integrated and direct lysis)
  • Show More (6)

News & Updates

Report on preparations to start US clinical trials for a near-patient molecular diagnostic system and multiplex respiratory test.

Announcement of expansion of veterinary molecular diagnostic portfolio with additional assays.

Received 'Excellence in Diagnostic Innovation' at a regional MedTech awards event.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.